ARGX-113
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for ARGX-113, covering 2020-12-14 to 2024-05-23. Get the full timeline:
Most recent: Clinical Trial Update: IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers [Phase 1]